Hook & thesis
Roper Technologies (ROP) is a classic cash compounder: a diversified portfolio of vertical software franchises and technology-enabled niche hardware, generating strong free cash flow and returning capital through buybacks and a rising dividend. The company reported Q2 2026 revenue of $2.11 billion with 9% total growth and raised full-year adjusted DEPS guidance to $22.15-$22.30 — signs that the core model remains intact.
That said, the market has punished ROP earlier this year — the stock traded down to $305.96 in mid-May before recovering toward $413 today. For investors who want exposure to high-quality recurring-revenue businesses but also want a clearly defined downside guardrail, this is an attractive buy-on-weakness opportunity. Target upside is toward $480 over a 180-trading-day stretch, with a protective stop at $385 to limit drawdowns should macro or company-specific risks re-emerge.
Why the market should care - business and fundamental driver
Roper is not a single-product software company. It operates three segments: Application Software, Network Software, and Technology Enabled Products. The combined effect is a diversified stream of recurring revenue from vertical SaaS businesses (Deltek, Vertafore, Frontline Education, etc.), freight and logistics intelligence (DAT, IntelliTrans), and specialized hardware (CIVCO Medical, Verathon).
That mix matters because it produces high free cash flow and gives management optionality: invest in organic product development (AI product launches were highlighted by management), tuck in acquisitions where they see niche leadership, or return cash to shareholders. Through 07/23/2026 management reported year-to-date repurchases of 9.0 million shares for $3.2 billion — a sizable share reduction against ~98.9 million shares outstanding. Free cash flow sits at approximately $2.62 billion, which supports the dividend and buybacks without stretching the balance sheet.
Recent financials and the numbers that matter
- Q2 2026 revenue: $2.11 billion, total growth 9%, organic ~5%.
- Q2 2026 adjusted DEPS: $5.38, up 10% year-over-year.
- Full-year 2026 guidance raised to adjusted DEPS of $22.15 - $22.30, with organic revenue growth of ~6% (management commentary).
- Free cash flow: ~$2.62 billion (most recent reported figure).
- Market cap: ~$40.7 billion; enterprise value: ~$51.7 billion.
- Valuation multiples: P/E ~17, price-to-free-cash-flow ~15.5, EV/EBITDA ~18.5.
These numbers describe a company with steady profitability and capital return. Return on equity of ~13.4% and debt-to-equity of ~0.61 indicate a healthy balance sheet — levered but not overlevered. Dividend per share is $0.91 quarterly, a yield of roughly 0.9% at current levels, and management has a long history of raising the payout.
Valuation framing
At a market cap of ~$40.7B and a P/E in the mid-teens (~17), Roper sits at a reasonable multiple for a business growing mid-single digits organically but generating strong free cash flow. Price-to-free-cash-flow of ~15.5 is neither cheap nor frothy for a high-quality software-plus-hardware conglomerate. EV/EBITDA at ~18.5 implies the market is paying for durable profitability and tuck-in M&A optionality.
Compare that to high-growth pure-play SaaS where P/FCF can run multiples far higher; Roper's blended multiple reflects the slower organic growth profile but lower execution risk and better cash conversion. Historically, Roper has traded through cycles: when acquisition cadence and buybacks accelerate with consistent cash flow, the multiple has expanded; during macro slowdowns its multiple compresses. This trade assumes the business re-accelerates modestly and multiple expands back toward historically normal levels, driven by buybacks, margin improvement, and AI product monetization.
Catalysts (what could drive the trade)
- Execution on AI-enabled product launches across application and network software — further monetization would lift growth and margins.
- Continued aggressive share repurchases: management repurchased $3.2B YTD and has room to continue using FCF.
- Upward revisions to full-year guidance if organic growth proves stronger than ~6% or margins expand further.
- Improving freight & logistics pricing environment lifting DAT and related network software EBITDA.
- Strategic tuck-in acquisitions that add high-margin recurring revenue without overstretching the balance sheet.
Trade plan (actionable)
Entry: Buy at $410.00. This is a buy-on-weakness entry slightly below recent closes, intended to capture a better risk/reward while still participating in continued recovery.
Stop loss: $385.00. A break below $385 would signal meaningful deterioration in momentum and risk to a lower trading range (and re-test of May lows), so close the position to preserve capital.
Target: $480.00. This target assumes a re-rating and partial recovery toward the prior structural highs; it represents ~16% upside from a $413 reference point and gives room for multiple expansion with steady organic growth and continued buybacks.
Position sizing & time horizon: Size the position modestly (example: 2-4% of portfolio) given cyclical exposures in parts of the business. Horizon: long term (180 trading days). The reasoning: AI rollout, buyback impact, and full-year guidance realization play out over multiple quarters; 180 trading days allows for multiple catalysts to crystallize while limiting prolonged exposure to macro shocks.
Note on intermediate timeframes: If you prefer a shorter window, a mid-term view (45 trading days) could work if an earnings or guidance update accelerates sentiment. For short-term traders (10 trading days) the focus should be on technical entry and day-to-day liquidity; this recommendation is primarily a long-term (180 trading days) trade.
Technical context
Shorter-term technicals show momentum rebuilding: the 10- and 20-day SMAs are above the 50-day SMA, and the 9-day EMA is above the 21-day EMA — constructive for further gains. RSI sits around 66, suggesting the stock is not yet in overbought territory but has room to run. Be mindful that the MACD histogram has recently gone slightly negative — a sign momentum may need confirmation with fresh buyers.
Risks and counterarguments
- Macro slowdown: A broad economic slowdown would pressure capital spending and some of Roper's industrial/hardware segments, compressing growth and margins.
- M&A execution risk: Roper's playbook depends on disciplined acquisitions. A misstep or overpaying for a tuck-in could weaken returns and deprioritize buybacks/dividends.
- Sentiment and technical volatility: Elevated short-volume in recent sessions and days-to-cover above 5 suggest periodic swings; trading volatility could force stop-outs for size-unadjusted positions.
- Valuation compression: If multiple contracts (e.g., EV/EBITDA drops below 15) even steady earnings could produce negative returns for equity holders.
- Hardware cyclicality: Some Technology Enabled Products are tied to capital equipment cycles (medical devices, instrumentation) which can be lumpy and sensitive to hospital and industrial spending.
Counterargument: One could argue Roper is already fairly valued given mid-single-digit organic growth and an EV/EBITDA near 18.5; if multiple re-rating stalls and the business only grows at ~5% organically, upside to $480 may be limited. That is a valid view, and it supports a modest position size and the $385 stop to protect capital.
What would change my mind
I would become more bullish if management demonstrates sustained organic growth above 7% for consecutive quarters, AI product revenue proves durable, and buybacks continue at the current cadence without resorting to excessive leverage. Conversely, a sustained deterioration in free cash flow, a material acquisition that dilutes returns, or a move below $385 on rising volume would make me step back and reassess.
Conclusion
Roper is a high-quality, cash-generative franchise with a diversified revenue base, strong free cash flow, and shareholder-friendly capital deployment. That combination is worth owning, but the path to upside is not frictionless. For investors who want exposure but also want to manage downside, the proposed buy-on-weakness trade at $410 entry, $385 stop, and $480 target over 180 trading days offers a pragmatic balance of upside capture and risk control.
| Metric | Value |
|---|---|
| Current Price | $413.00 |
| Market Cap | $40.7B |
| Free Cash Flow | $2.62B |
| P/E | ~17 |
| EV/EBITDA | ~18.5 |
| 52-Week Range | $305.96 - $538.21 |
| Quarterly Dividend | $0.91 |
Execution checklist
- Enter at $410.00, size 2-4% of portfolio or adjust by risk tolerance.
- Set stop loss at $385.00 and consider trailing it after $440-$450 is achieved.
- Re-evaluate position on the next quarterly update or on incremental signs of margin expansion or organic acceleration.
Trade idea summary: Selective long at $410.00 with a $385 stop and $480 target over 180 trading days. Quality business, reasonable valuation, but manage size and respect downside risks.